Safe, tolerable and successful escalation up to target dose.
That’s all we could reasonably ask Santa for at this stage and he’s delivered in spades.
Wishing a safe and Merry Christmas to all. What a year 2023 is going to be for the Mighty Neuren!
Ann: Neuren submits IND & first patients complete Phase 2 trials, page-10
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$13.28 |
Change
0.430(3.35%) |
Mkt cap ! $1.652B | |||
| Open | High | Low | Value | Volume |
| $13.15 | $13.37 | $12.92 | $4.153M | 316.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 35 | $13.28 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $13.29 | 380 | 6 |
View Market Depth
| Last trade - 12.00pm 18/06/2025 (20 minute delay) ? |
| NEU (ASX) Chart |